We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

2 hedge funds and large institutions have $1.5M invested in Abiomed Inc in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% less capital invested

Capital invested by funds: $4.62M → $1.5M (-$3.12M)

75% less funds holding

Funds holding: 82 (-6)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
2
Holders Change
-6
Holders Change %
-75%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

ABMD Hedge Fund Activity: Q1 2023 in Review

2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2023, worth a combined $1.5M — down 68% from $4.62M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ABMD and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Blue Trust Inc, exiting entirely with an estimated $1.21M sold.

  • 2 institutional investors held Abiomed Inc (ABMD) as of Q1 2023, down from 8 in Q4 2022.
  • Funds reported $1.5M of Abiomed Inc stock for Q1 2023, down 68% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q1 2023 and 6 closed out, a net change of -6 holders.
  • The largest Abiomed Inc seller in Q1 2023 was Blue Trust Inc, an estimated $1.21M sold.

Based on aggregated 13F filings for Q1 2023.